Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
Tomohiro Iida,1 Keirei Ishii2 1Department of Ophthalmology, Tokyo Women’s Medical University, Tokyo, 2Health Economics and Outcomes Research, Bayer Yakuhin Ltd., Osaka, Japan Purpose: The purpose of this study was to monitor anti-vascular endothelial growth factor (anti-VEGF) tr...
Saved in:
Main Authors: | Iida T, Ishii K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/ed93e2d55e3748ca8d0f4ada973f89e0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
by: Varano M, et al.
Published: (2016) -
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
by: Amoaku W, et al.
Published: (2018) -
Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration
by: Taipale C, et al.
Published: (2018) -
Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
by: Garweg JG
Published: (2019) -
Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
by: Bek T, et al.
Published: (2018)